Publications Database

Alberti A. et al. (1999)

Sulphation deficit in 'low-functioning' autistic children: a pilot study.

Biological Psychiatry

46(3), pp. 420-424.

Amiet C. et al. (2008)

Epilepsy in autism is associated with intellectual disability and gender: Evidence from a meta-analysis.

Biological Psychiatry

64(7), pp. 577-582

Read Abstract (New Window)

Amminger G. et al. (2007)

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

Biological Psychiatry

61(4), 551-553

Read Abstract (New Window)

Ashwin E. et al. (2009)

Eagle-eyed visual acuity: An experimental investigation of enhanced perception in autism.

Biological Psychiatry

65(1), pp. 17-21

Read Abstract (New Window)

Bethea T. C. , Sikich L. (2007)

Early pharmacological treatment of autism: a rationale for developmental treatment.

Biological Psychiatry

61(4), pp. 521-537

Read Abstract (New Window) Read Full (New Window)

Campbell M. (1975)

Pharmacotherapy in early infantile autism.

Biological Psychiatry

10(4), pp. 399-423

Read Abstract (New Window)

D'Urso G. et al. (2014)

Transcranial direct current stimulation for autistic disorder.

Biological Psychiatry

September, 1(76), e5-6.

Read Abstract (New Window)

Domes G. et al. (2013)

Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.

Biological Psychiatry

74(3), pp. 164-171.

Read Abstract (New Window)

Fecteau S. et al. (2017)

Parenting stress and salivary cortisol in parents of children with autism spectrum disorder: Longitudinal variations in the context of a service dog’s presence in the family.

Biological Psychiatry

February, 122 pp. 187-195.

Read Abstract (New Window)

Gilbert D. (2008)

Regarding 'omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study'.

Biological Psychiatry

63(2), e13; author reply e15

Green L. et al. (2001)

Oxytocin and autistic disorder: Alterations in peptide forms.

Biological Psychiatry

50 pp. 609-613.

Read Abstract (New Window)

Guastella A. J. et al. (2010)

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Biological Psychiatry

67(7), pp. 692-694

Read Abstract (New Window)

Guastella A. J. , Hickie I. B. (2016)

Oxytocin treatment, circuitry and autism: A critical review of the literature placing oxytocin into the autism context

Biological Psychiatry

79(3), pp. 234-242.

Read Abstract (New Window)

Hardan A. Y. et al. (2012)

A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Biological Psychiatry

71(11), pp. 956-961.

Read Abstract (New Window)

Hollander E. et al. (2007)

Oxytocin increases retention of social cognition in autism.

Biological Psychiatry

61(4), pp. 498-503

Read Abstract (New Window) Read Full (New Window)

Insel T. R. , O'Brien D. , Leckman J. F. (1999)

Oxytocin, vasopressin, and autism: is there a connection?

Biological Psychiatry

45(2), pp.145-157

Read Abstract (New Window)

Martineau J. , Garreau B. , Barthélémy C. (1981)

Effects of vitamin B6 on averaged evoked potentials in infantile autism.

Biological Psychiatry

16(7), pp. 627-641

Read Abstract (New Window)

Martineau J. , Barthélémy C. , LeLord G. (1986)

Long-term effects of combined vitamin B6-magnesium administration in an autistic child.

Biological Psychiatry

21(5), pp. 511-518

Martineau J. et al. (1985)

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

Biological Psychiatry

20(5), pp. 467-478

Read Abstract (New Window)

Posey D. J. et al. (2007)

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Biological Psychiatry

61(4), pp. 538-544.

Read Full (New Window)